相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International Classification of Retinopathy of Prematurity, Third Edition
Michael F. Chiang et al.
OPHTHALMOLOGY (2021)
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity
David K. Wallace et al.
JAMA OPHTHALMOLOGY (2020)
Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial
Matthew Fidler et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)
Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment
Girija Natarajan et al.
PEDIATRICS (2019)
Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Muller cells maintains retinal function by triggering different signaling mechanisms
Silke Becker et al.
SCIENTIFIC REPORTS (2018)
Screening Examination of Premature Infants for Retinopathy of Prematurity
Walter M. Fierson
PEDIATRICS (2018)
RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY A Longitudinal Fluorescein Angiographic Study
Birgit Lorenz et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity A Phase 1 Dosing Study
David K. Wallace et al.
JAMA OPHTHALMOLOGY (2017)
Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity
Gunnel Hellgren et al.
PEDIATRIC RESEARCH (2016)
Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity
Julie Morin et al.
PEDIATRICS (2016)
Pharmacokinetics of Bevacizumab and Its Effects on Serum VEGF and IGF-1 in Infants With Retinopathy of Prematurity
Lingkun Kong et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
REACTIVATION OF RETINOPATHY OF PREMATURITY AFTER RANIBIZUMAB TREATMENT
Ryan K. Wong et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity
Wei-Chi Wu et al.
JAMA OPHTHALMOLOGY (2015)
Structural, Visual and Refractive Outcomes of Intravitreal Aflibercept Injection in High-Risk Prethreshold Type 1 Retinopathy of Prematurity
Abdelrahman G. Salman et al.
OPHTHALMIC RESEARCH (2015)
Refractive Outcomes Following Bevacizumab Monotherapy Compared With Conventional Laser Treatment A Randomized Clinical Trial
Megan M. Geloneck et al.
JAMA OPHTHALMOLOGY (2014)
Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity
Maria Ana Martinez Castellanos et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Anti-VEGF Antibody Leads to Later Atypical Intravitreous Neovascularization and Activation of Angiogenic Pathways in a Rat Model of Retinopathy of Prematurity
Manabu McCloskey et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity
Tatsuhiko Sato et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II
Rudolf Autrata et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2012)
Appropriate Use and Reporting of Uncontrolled Case Series in the Medical Literature
John H. Kempen
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity.
Helen A. Mintz-Hittner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Role of VEGF in organogenesis
Jody J. Haigh
Organogenesis (2010)
Anti-vascular endothelial growth factor and retinopathy of prematurity
Jonathan E. Sears
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
S. Kusaka et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
分享论文
